Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GBAS | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | MAP3K8 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
mRNA | ZIC5 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | C2CD4C | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | MED1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | DMRT2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | RGS17 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | NOB1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | ALG6 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | GFRA3 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |